aTyr Pharma (LIFE) Insider Trading & Ownership → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free LIFE Stock Alerts $1.90 +0.05 (+2.70%) (As of 06/4/2024) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends aTyr Pharma (NASDAQ:LIFE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$136,160.00Number OfInsiders Selling(Last 12 Months)0 Get LIFE Insider Trade Alerts Want to know when executives and insiders are buying or selling aTyr Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LIFE Insider Buying and Selling by Quarter Ad DeFi Distribution[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially profit from this trillion-dollar niche WITHOUT buying a single coin, NFT or investing in ANYTHING.Grab the PDF here for free: aTyr Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/31/2024Jill Marie BroadfootCFOBuy5,000$1.79$8,950.00 5/31/2024Sanjay ShuklaCEOBuy20,000$1.81$36,200.00 5/30/2024Timothy CoughlinDirectorBuy50,000$1.75$87,500.00 12/11/2023Sanjay ShuklaCEOBuy3,000$1.17$3,510.00 (Data available from 1/1/2013 forward) LIFE Insider Trading Activity - Frequently Asked Questions Who is on aTyr Pharma's Insider Roster? The list of insiders at aTyr Pharma includes Jill Marie Broadfoot, Paul Schimmel, Sanjay Shukla, and Timothy Coughlin. Learn more on insiders at LIFE. What percentage of aTyr Pharma stock is owned by insiders? 3.70% of aTyr Pharma stock is owned by insiders. Learn more on LIFE's insider holdings. Which aTyr Pharma insiders have been buying company stock? The following insiders have purchased LIFE shares in the last 24 months: Jill Marie Broadfoot ($8,950.00), Paul Schimmel ($450,000.00), Sanjay Shukla ($104,310.00), and Timothy Coughlin ($87,500.00). How much insider buying is happening at aTyr Pharma? Insiders have purchased a total of 303,000 LIFE shares in the last 24 months for a total of $650,760.00 bought. Which aTyr Pharma insiders have been selling company stock? The following insider sold LIFE shares in the last 24 months: Jill Marie Broadfoot ($3,695.76). How much insider selling is happening at aTyr Pharma? Insiders have sold a total of 1,566 aTyr Pharma shares in the last 24 months for a total of $3,695.76 sold. More Insider Trading Tools from MarketBeat Related Companies: HBIO Insider Ownership PTCT Insider Ownership SRPT Insider Ownership TMO Insider Ownership A Insider Ownership MTD Insider Ownership ILMN Insider Ownership WAT Insider Ownership TECH Insider Ownership CRL Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (NASDAQ:LIFE) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding aTyr Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share aTyr Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.